DE69131481T2 - Bistriazene als chemotherapeutische mittel - Google Patents

Bistriazene als chemotherapeutische mittel

Info

Publication number
DE69131481T2
DE69131481T2 DE69131481T DE69131481T DE69131481T2 DE 69131481 T2 DE69131481 T2 DE 69131481T2 DE 69131481 T DE69131481 T DE 69131481T DE 69131481 T DE69131481 T DE 69131481T DE 69131481 T2 DE69131481 T2 DE 69131481T2
Authority
DE
Germany
Prior art keywords
bistriazene
compounds
cancer
chemotherapeutic agent
manipulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69131481T
Other languages
English (en)
Other versions
DE69131481D1 (de
Inventor
Christopher Michejda
Jeffrey Blumenstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States, AS REPRESENTED BY TH
Original Assignee
United States, REPRESENTED BY SECRETARY
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States, REPRESENTED BY SECRETARY, US Department of Commerce filed Critical United States, REPRESENTED BY SECRETARY
Application granted granted Critical
Publication of DE69131481D1 publication Critical patent/DE69131481D1/de
Publication of DE69131481T2 publication Critical patent/DE69131481T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/22—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond containing chains of three or more nitrogen atoms with one or more nitrogen-to-nitrogen double bonds
    • C07C245/24—Chains of only three nitrogen atoms, e.g. diazoamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69131481T 1990-05-24 1991-05-22 Bistriazene als chemotherapeutische mittel Expired - Fee Related DE69131481T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52791590A 1990-05-24 1990-05-24
PCT/US1991/003445 WO1991017753A1 (en) 1990-05-24 1991-05-22 Bistriazenes as chemotherapeutic agents

Publications (2)

Publication Number Publication Date
DE69131481D1 DE69131481D1 (de) 1999-09-02
DE69131481T2 true DE69131481T2 (de) 1999-11-25

Family

ID=24103474

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131481T Expired - Fee Related DE69131481T2 (de) 1990-05-24 1991-05-22 Bistriazene als chemotherapeutische mittel

Country Status (10)

Country Link
US (2) US5672593A (de)
EP (1) EP0531419B1 (de)
JP (1) JPH05506452A (de)
AT (1) ATE182468T1 (de)
AU (1) AU642273B2 (de)
CA (1) CA2083148C (de)
DE (1) DE69131481T2 (de)
DK (1) DK0531419T3 (de)
ES (1) ES2134778T3 (de)
WO (1) WO1991017753A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808038A (en) * 1990-05-24 1998-09-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bistriazenes as chemotherapeutic agents
WO1993009089A1 (en) * 1991-10-31 1993-05-13 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Bistriazenes as chemotherapeutic agents
CA2128342C (en) * 1993-07-22 1997-06-24 Jochen Dauth Organosilicon compounds having triazene groups
DE19508076C2 (de) * 1995-03-08 1998-04-30 Csb Syst Software Entwicklung Schaltungsanordnung zur Integration eines Sprachsystems in EDV-Systeme und Telefonanlagen, die an das öffentliche Telefonnetz angeschlossen sind
ZA973642B (en) * 1996-04-26 1997-11-25 Merck & Co Inc DNA vaccine formulations.
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
MXPA04002817A (es) 2001-09-27 2004-07-05 Pioneer Hi Bred Int Polinucleotidos de fitato y metodos de uso.
WO2003087313A2 (en) 2002-04-08 2003-10-23 Pioneer Hi-Bred International, Inc. Enhanced silk exsertion under stress
US7987056B2 (en) 2004-09-20 2011-07-26 The Regents Of The University Of Colorado, A Body Corporate Mixed-library parallel gene mapping quantitative micro-array technique for genome-wide identification of trait conferring genes
KR20160116056A (ko) 2008-08-14 2016-10-06 테바 파마슈티컬즈 오스트레일리아 피티와이 엘티디 항-ｉｌ-12/ｉｌ-23 항체
EP2557075A1 (de) 2011-08-09 2013-02-13 Trin Therapeutics GmbH Neue Triazenverbindungen zur Behandlung von Krebs
CA2853449A1 (en) 2011-10-25 2013-05-02 Pioneer Hi-Bred International, Inc. Methods to alter plant cell wall composition for improved biofuel production and silage digestibility

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138521A (en) * 1960-10-04 1964-06-23 Gen Aniline & Film Corp Fungicidal method
CH482789A (de) * 1967-03-16 1969-12-15 Ciba Geigy Verfahren zur Herstellung neuer Disazofarbstoffpigmente
DE1793115A1 (de) * 1968-08-03 1972-02-03 Bayer Ag Neue Triazenderivate
DE3426644A1 (de) * 1984-07-19 1986-02-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg N,n-bis((1-aryl-3-methyltriazen-3-yl) methyl)ether
US4923970A (en) * 1988-03-28 1990-05-08 Bionetics Research, Inc. Substituted 1-(2-chloroethyl)-3-acyl-3-alkyltriazenes

Also Published As

Publication number Publication date
AU642273B2 (en) 1993-10-14
US5672593A (en) 1997-09-30
AU8089791A (en) 1991-12-10
ES2134778T3 (es) 1999-10-16
WO1991017753A1 (en) 1991-11-28
EP0531419A4 (en) 1994-04-06
EP0531419A1 (de) 1993-03-17
DK0531419T3 (da) 1999-11-29
DE69131481D1 (de) 1999-09-02
CA2083148A1 (en) 1991-11-25
ATE182468T1 (de) 1999-08-15
CA2083148C (en) 2002-01-01
EP0531419B1 (de) 1999-07-28
JPH05506452A (ja) 1993-09-22
US5731301A (en) 1998-03-24

Similar Documents

Publication Publication Date Title
DE69131481D1 (de) Bistriazene als chemotherapeutische mittel
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
DE69535805D1 (de) Neue Carbamate- und Harnstoffderivate als Mittel gegen Multidrugresistenz
MX9605665A (es) Bis (resorcinil) triazinas.
KR960004344A (ko) 6원 질소 함유 헤테로아릴-옥사졸리디논
DE69417012D1 (de) Cyclobutan-derivate als inhibitoren der squalen-synthetase und der protein-farnesyltransferase
LU88317I2 (fr) Chlorhydrate d'esmolol (Brevibloc)
ATE218142T1 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
DE3031710C2 (de) Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen.
ATE45153T1 (de) Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
DE68913762D1 (de) Diarylverbindungen als antiatherosklerotische Mittel.
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
DE59203006D1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel.
DE69110507D1 (de) Esterderivate von siloxanen und kosmetische Zusammensetzungen die diese Derivate enthalten.
NO960632L (no) Nye bis-naftalimider for behandling av kreft
AU549890B2 (en) Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
DE59409456D1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
ATE250610T1 (de) Kaliumkanal-blockierende mittel
ATE189207T1 (de) Bistriazene als chemotherapeutische wirkstoffe
FI884838A0 (fi) Nytt s-timololderivat och foerfarande foer dess framstaellning.
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
DE3669713D1 (de) Alkylaminoamide und ihre salze, ihre herstellung, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen.
KR950702942A (ko) 암의 간전이 억제용 의약 조성물 및 간암 치료용 의약 조성물(pharmaceutical compositions for preventing liver metastasis of cancer and pharmaceutical composition for the treatment of liver cancer)
GB1333565A (en) Therapeutic compositions
RU94033096A (ru) Соединение, способ лечения и фармацевтическая композиция

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH

8339 Ceased/non-payment of the annual fee